Stock Market Reviews

Read and share opinions on AVTX (Avalo Therapeutics, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market

Latest News

• Avalo Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Updates
  Nov 6, 2025
• Avalo Therapeutics to Participate in Upcoming Investor Conferences
  Nov 3, 2025
• Piper Sandler Maintains Bullish $48 Price Target on Avalo Therapeutics (AVTX)
  Oct 29, 2025
• Avalo Therapeutics Announces Completion of Enrollment in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa
  Oct 29, 2025
• Avalo Therapeutics Expands Leadership Team with Key Appointments in Business Development and Human Resources
  Oct 1, 2025
• Avalo Therapeutics Appoints Kevin R. Lind to Board of Directors
  Sep 22, 2025
• Avalo Reports Second Quarter 2025 Financial Results and Recent Business Updates
  Aug 7, 2025
• Avalo Adds Dr. Rita Jain to Board as LOTUS Trial Advances
  Jul 3, 2025
• Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors
  Jun 18, 2025
• Avalo Therapeutics to Participate in The Citizens Life Sciences Conference
  Apr 30, 2025
• Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board
  Mar 26, 2025
• Avalo Reports 2024 Financial Results and Recent Business Updates
  Mar 20, 2025
• Avalo Therapeutics to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
  Feb 4, 2025
• Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy Officer
  Jan 2, 2025
• Avalo Therapeutics initiated with a Buy at BTIG
  Dec 20, 2024